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Abstract
Human herpesvirus 7 (HHV-7) is a betaherpesvirus, and is phylogenetically related to both HHV-6A and HHV-6B. The
presence of telomeric repeat sequences at both ends of its genome should make it equally likely to integrate into the human
telomere as HHV-6. However, numerous studies have failed to detect germline integration of HHV-7, suggesting an important
difference between the HHV-6A/-6B and HHV-7 genomes. In search of possible germline integrated HHV-7, we developed a
sensitive and quantitative real-time PCR assay and discovered that primers designed against some parts of the HHV-7
genome can frequently miss HHV-7 positive clinical samples even though they work efficiently in cell-culture-derived HHV-7
positive materials. Using a primer pair against the U90 ORF of HHV-7, we identified a possible case of germline integration
of HHV-7 with one copy of viral genome per cell in both peripheral blood cells and hair follicles. Chromosomal integration of
HHV-7 in these individuals was confirmed by fluorescence in situ hybridization analysis. Germline integration of HHV-7 was
further confirmed by detection of ~2.6 copies of HHV-7 in the hair follicles of one of the parents. Our results shed light on the
complex nature of the HHV-7 genome in human-derived materials in comparison to cell-culture-derived materials and show
the need for stringent criteria in the selection of primers for epidemiological HHV-7 studies.
INTRODUCTION
Human herpesvirus 7 (HHV-7) is a member of the genus
Roseolovirus of the subfamily Betaherpesvirinae, and is
closely related to HHV-6A and HHV-6B. It is lympho-
tropic, neurotropic, and shares disease associations such as
febrile seizures, febrile status epilepticus, encephalitis and
skin rash [1–6]. Like HHV-6B, HHV-7 is highly prevalent,
with 75–90% of healthy adults harbouring the virus [7, 8].
Infectious HHV-7 is frequently present in the saliva of
healthy humans [9]. However, unlike HHV-6A/-6B, little is
known about the mechanisms of HHV-7 persistence and
latency.
Although somewhat shorter (145 kb vs ~160 kb) and overall
more compactly arranged, the HHV-7 genome shares similar-
ities with both HHV-6A and HHV-6B genomes, including
eukaryotic-telomere-related sequence arrays in the direct
repeat (DR) elements at the ends of the respective genomes
(DRL and DRR) [1]. The presence of telomeric repeats at
HHV-6A/-6B genomic termini enables the viral genomes to
integrate into host-cell telomeres via homologous recombina-
tion [10, 11]. Such integration can occur in germline cells to
initiate genetic lineages in which the virus genome is transmit-
ted to offspring through the germline, resulting in genomic
integration of the virus in a specific chromosome in every
nucleated cell [12–14]. This germ-line chromosomally inte-
grated HHV-6 (ciHHV-6) can be activated to a transmissible
infectious form in cultured cells [15–18]. Recent evidence sug-
gests that the integrated virus can produce infectious virions
in vivo in pregnant ciHHV-6 women [13] and under condi-
tions of immunosuppression [19]. Excision of chromosomally
integrated viral genomes appears to occur via homologous-
recombination-mediated telomeric circle (t-circle) formation
[16, 17].
Based on the similarities between HHV-6A, HHV-6B and
HHV-7, we hypothesized that HHV-7 genomes might also
integrate into human telomeres in a manner similar to
HHV-6. While developing a sensitive and quantitative PCR
assay, we observed that certain genomic regions of HHV-7,
in in vivo patient samples as well as in vitro cultured cells
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carrying integrated HHV-7, are easily amplifiable by PCR
whereas others are not. Genetic polymorphism between
HHV-7 in the human population has been described else-
where [20]. However, we could not see sequence variations
that could explain the differences in the PCR results
between HHV-7 positive in vivo patient materials and in
vitro cell-culture-derived samples. However, using a newly
developed primer pair against the HHV-7 U90 ORF, we
were able to detect HHV-7 in all patient samples, which
helped us identify two possible cases of germline integration
of HHV-7 genomes.
RESULTS
Development of quantitative real-time PCR (qPCR)
assays and a cell line carrying latent
chromosomally integrated HHV-7
We compared the genome sequences of HHV-7 type JI
(U43400.1), RK (AF037218.1) and UCL-1 (KF558370.1)
strains, and selected four different regions of the HHV-7
genome [U4, U54, gB (glycoprotein B) and U90] that had
100% conserved sequences among these strains. In order to
develop a standard curve, we amplified stretches of HHV-7
DNA from these four regions of HHV-7(JI) strain undergo-
ing active infection in SupT1 cells (Fig. 1a) using viral-gene-
specific primers [indicated as external primers to mark
them different from another internal set of primers within
the same region (Table S1, available in the online Supple-
mentary Material)] and cloned them into pCR2.1 vector to
create a known number of copies of the desired viral geno-
mic region. Using a second set of internal primers
(Table S1) and 10-fold serial dilutions of a known number
of viral genomic copies, we tested and created standard
curves that showed amplification of 10 to 106 genome equiv-
alents of the desired viral DNA with more than 99% effi-
ciency (Fig. 1b) [limit of detection (LOD) = 10 copies per
reaction] in the presence of spiked cellular DNA. Total cel-
lular DNA (100 ng) containing a known number of genome
equivalents of viral DNA was used in every qPCR reaction.
We amplified the cellular gene PI15, present at two copies
per human cell, in parallel [18] to normalize the viral
genome copy number and to calculate the number of host
cell copies per reaction. HHV-7(JI)-infected SupT1 cultured
cells were used as a positive control because amplimers were
successfully obtained using total DNA derived from these
cells in all the four primer pairs.
To test the efficiency of these primers in the case of latent
virus infection, we created a latent HHV-7-like cell line by
infecting SupT1 cells with HHV-7(RK) strain (named here-
after as Sup.H7). After long-term passaging and cell sorting,
we identified a single-cell-derived clone that continuously
remained HHV-7 positive (Fig. 2a, Table 1) without any
visual signs of productive viral infection (no cytopathic
effect). These cells were treated with a known inducer of
ciHHV-6, hydrocortisone (10 5M) [15, 18] to activate viral
DNA replication. Enlargement of the cell body, a hallmark
of HHV-7 activation, was found in 5–10% of the infected
cells within 2 weeks of hydrocortisone treatment (Fig. 2b).
The amount of viral DNA was quantified by qPCR using
the internal U4 primer pair, which showed increased viral
load. Hydrocortisone treatment increased the viral load up
to 12-fold by 5 weeks post-infection (wpi) (Fig. 2c). Immu-
nostaining of activated cells using two different mAbs
against HHV-7 early antigen U27 and late antigen (KR4),
which detects an unknown late viral protein [21, 22], was
positive, confirming the reactivation of HHV-7 (Fig. 2d).
U27 was detected mostly within the nucleus of activated
cells, whereas KR4 antibody detected viral proteins within
the cytoplasm of activated cells. To assess viral genes associ-
ated with activation, viral transcription was analysed in the
activated cells in comparison to the untreated counterpart
cells using different primer pairs. Interestingly, we observed
transcription of HHV-7 U4 and gB (Fig. 2e) only in hydro-
cortisone-treated cells at 2 wpi, indicating that these tran-
scripts might serve as a marker for viral activation. HHV-7
U90, U20 and U54 transcripts were detected in lower
amounts in non-activated cells, which subsequently
increased after viral reactivation.
Transmission electron microscopy confirmed herpesvirus-
like particles that lacked discernible envelopes (Fig. 2f),
thereby indicating incomplete viral activation. Consistent
with this, very little infectivity was recovered. These Sup.H7
cells carrying quiescent HHV-7(RK) were tested for chro-
mosomal integration by fluorescence in situ hybridization
(FISH) analysis (Fig. 2g), which showed probable telomeric
integration of HHV-7. With these results, we confirmed
generation of a clonal population of cells with chromosom-
ally integrated HHV-7, which was in a latent stage and capa-
ble of reactivation with external stimuli.
Total cellular DNA from these cells was tested using all four
internal qPCR primer pairs, which detected ~1 genome
equivalent of HHV-7 per cell (Tables 1 andS2). DNA from
these cells was used as a positive control in all the subse-
quent qPCR studies. With this we validated a latent HHV-7
cell line that carried ~1 copy of HHV-7 in a chromosomally
integrated state and four pairs of primers that amplified
four different viral regions with equal efficiency.
Possible germline integration of HHV-7 in two
individuals
As a next step, we tested the effectiveness of our qPCR assays
to detect HHV-7 in additional patient-derived DNA samples.
In the course of the investigation, we came across two unusual
clinical cases positive for HHV-7. In the first case (patient 1),
a 1-day-old newborn was detected with hypoglycaemia. Dur-
ing routine testing carried out in such cases, HHV-7 was
detected by PCR in cerebrospinal fluid, but not in serum. The
baby tested negative for HHV-6, Epstein-Barr virus, human
cytomegalovirus and other pathogens in the cerebrospinal
fluid. Serum samples from the mother and the father were
also negative for HHV-7. We analysed DNA derived from the
whole blood of this child as well as hair follicles for HHV-7
(Table 1). We detected a low level of HHV-7 in the whole
blood (0.01 genome equivalents per cell), but 1 genome
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equivalent of HHV-7 per cell in hair follicles (Table 1) using
the U90 primer pair, whereas other primer pairs could not
amplify viral DNA in both types of samples. Similar results
were also obtained from whole-blood and hair-follicle samples
derived from the mother (0.01 genome equivalents of HHV-7
per cell in whole blood but 1 genome equivalent per cell in the
hair follicles) (Table 1). We could not obtain samples from the
father. Genetic polymorphism and sequence variations of
HHV-7 in the human population have been described in the
past [20] that can prevent PCR amplification. Hence, we used
three of the external primer pairs (U54, gB and U90) to
amplify HHV-7 genomic regions from blood and hair follicles
in both the mother and the baby, and detected a very low
amount of PCR DNA in some of the samples (Fig. 3a). Puri-
fied PCR products were sequenced directly and were com-












T1 T2 T1 T2
DRR
gB U54 U90























101 102 103 104 105 106
101 102 103 104 105 106 101 102 103 104 105 106





































































Fig. 1. qPCR assay to detect HHV-7. (a) Schematic representation showing approximate location of the four different regions of
the HHV-7 genome selected for PCR analysis. Similarities between the genomic organization of HHV-6A (HHV-6B) and HHV-7 are
marked by DRL and DRR; packaging signal sequences (pac1 and pac2) within the HHV-7(JI) (GenBank accession no. U43400.1) are
shown. Stretches of heterogeneous telomeric repeat sequences are indicated by blue boxes, and stretches of homogeneous telomeric
repeat sequences are indicated by red boxes. DRL, Left DR; DRR, right DR; T1, telomeric repeat 1; T2, telomeric repeat 2. (b) Standard
curve analysis of U4, U54, gB and U90 regions of HHV-7 using specific primer pairs. Tenfold serial dilutions of plasmids carrying
the respective regions were tested in triplicate by qPCR. Mean quantification cycle (Cq) values are plotted against the copy numbers.
Correlation coefficients and slope values are given in each graph panel.
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Fig. 2. Sup.H7 cells carry ~1 genome equivalent of latent and chromosomally integrated HHV-7. (a) The PCR efficiency of four sets of
primers was tested in Sup.H7 cells and compared to that of blood-derived DNA from patient 2. Amplimers from external primer pairs
are marked by black arrowheads and those from internal primer pairs are marked by red arrowheads. (b) Activated Sup.H7 cells
induce syncytia formation. Sup.H7 cells were treated with 10 5M hydrocortisone for 2 weeks. Enlarged cells (marked with a white
arrow) representing activated HHV-7 were detected forming large clumps (right panel) by phase contrast microscopy. Solvent control
(ethanol) treated cells (left panel) did not show such characteristic features of viral activation. (c) The increase in the amount of viral
DNA was quantified by qPCR. Sup.H7 cells were treated with 10 5M hydrocortisone for different time intervals. Total genomic DNA
was isolated and used for qPCR. Ethanol-treated (Eth. only) cells were used as a control. **, p<0.005. (d) Immunostaining using mAbs
against HHV-7 (red staining in the images) identified activated Sup.H7 cells. Hydrocortisone treatment was carried out for 2 wpi. HHV-
7-specific staining is marked with white arrows. DAPI staining is blue/green in the images. Bars, 50 µm. (e) Transcription profile of
viral genes after HHV-7 activation in Sup.H7 cells. Total RNA from Sup.H7 cells, either infected with Chlamydia trachomatis (+Ctr) for
2 weeks or treated with different chemical stimuli like trichostatin A (TSA) or hydrocortisone, was used for reverse transcription PCR
(RT-PCR). Primers designed against HHV-7 U4, U20, U54, U90 and gB were used for the the PCR. Amplification of GAPDH was used as
a control. (f) Transmission electron microscopy identified unique herpesvirus-like particles after hydrocortisone treatment in induced
cells. The insets show a few viral particles at higher magnification identifying nucleoid, nuclear membrane and tegument, yet no enve-
lope. These viral structures are comparable with HHV-7 particles. Both pictures (top and bottom panels) represent hydrocortisone-
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(RK) strain. We could not see any sequence variations within
the analysed genomic regions. Subsequent FISH analysis using
peripheral-blood-derived PBMCs from both the baby
(Fig. 3b) and the mother (Fig. 3c) detected integrated HHV-7
in the telomeric regions of a few cells supporting possible rare
chromosomal integration of HHV-7.
In a second case (patient 2), a 34-year-old male suffering
from chronic fatigue syndrome tested positive for HHV-7
during routine analysis using a commercial kit (Genesig;
PrimerDesign). We tested the blood-derived DNA from
this patient in our qPCR assay and found 1 genome equiv-
alent of HHV-7 per cell in the blood (Table 1). Like our
previous results, only the U90 primer pair successfully
amplified the viral genome, whereas U4, U54 and gB
primer pairs could not detect any viral DNA (Fig. 2a).
Subsequently, we tested hair follicles from this patient and
found ~1 genome equivalent of HHV-7 per cell using only
the U90 primer pair (Table 1). Analysis of hair follicles
from both the parents detected ~2.6 genome equivalents of
HHV-7 per cell in the mother’s hair, whereas no viral
DNA was detected in the father (Table 1). We could not
get consent from both the parents for blood collection and
analysis. Subsequent FISH analysis using blood-derived
PBMCs from the patient detected possible integrated
HHV-7 in the telomeric regions (Fig. 3d). Thus, we found
strong evidence for possible chromosomal integration and
genetic inheritance of HHV-7.
We utilized DNA derived from the blood of patient 2 hav-
ing 1 copy of HHV-7 per cell in blood and hair follicles for
further analysis of negative PCR results from certain viral
genomic regions. The presence of complex and highly sta-
ble genomic structures, including but not limited to hairpin
stem-loop structures and G-quadruplexes [23], within the
target region might inhibit the efficiency of PCR amplifica-
tions. To verify such a situation leading to inefficient PCR
amplification within U4, gB and U54, we carried out nested
PCRs using the internal primers and the PCR amplimers
derived using external primer pairs (Fig. 3e). The desired
PCR products were obtained during the nested PCR of gB
and U54 regions, suggesting that due to some unknown
factors PCR amplification from U54 and gB was not highly
effective during the first PCR. Nested PCR products were
further sequenced to validate the amplimers. These results
suggested that even if most of the viral genomes are present
within a sample, successful identification and quantification
of the HHV-7 might depend upon the sample type and the
efficiency of the selected primers to amplify that genomic
region.
treated activated Sup.H7 cells from two independent experiments. Bars, 0.5 µm. Red arrows indicate viral particle like structures.
(g) FISH image of Sup.H7 cells showing the association of HHV-7 with host cell chromosomes. Sup.H7 metaphase spreads were
stained with a Cy5-labelled HHV-7 probe (green) and a FITC-labelled telomeric PNA probe (red). DNA was stained with DAPI
(blue). Chromosomal integration sites of HHV-7 are indicated with white arrows at 60 magnification. Due to the tetraploid nature of
the cells, two integration sites are detected within a single metaphase spread. The insets show magnified images of chromosomes
carrying integrated HHV-7. HC, Hydrocortisone
Table 1. HHV-7 copy numbers as quantified by qPCR in different types of biological materials
















26.34 1655 22.5 1687.5 23.9 1639.6 25 1660.7 22.26 1639.11 ~1.1
Case 1
Blood (patient 1) 34.13 7.01* 35.12 0.155* 32.56 3.88* 30.04 39.76 21.27 3673.88 0.01
Hair (patient 1) 37.15 0.84* 36.79 0.04* 33.15 2.57* 28.91 91.54 26.00 77.7 1.17
Blood (mother of
patient 1)
35.02 3.75* 34.97 0.17* 32.97 2.91* 28.51 123.571 19.89 11314 0.01
Hair (mother of
patient 1)
34.92 4.02* 37.12 0.03* 31.68 7.18* 29.79 47.95 26.69 44.27 1.07
Case 2
Blood (patient 2) 33.87 8.41* 27.05 59.09 32.12 5.28* 20.34 52056.04 18.17 45658 1.14
Hair (patient 2) 34.32 6.13* 34.30 0.28* 31.45 8.43* 29.15 76.56 26.23 64.4 1.18
Hair (mother of
patient 2)
36.12 1.73* 37.45 0.02* 32.33 4.56* 29.5 59.21 27.49 23.06 2.6
Hair (father of
patient 2)
37.38 0.71* 34.97 0.02* 32.13 5.24* 32.98 4.52* 27.86 34.11 <LOD
*Below LOD.













































































































Fig. 3. Chromosomal integration and possible inheritance of HHV-7. (a) HHV-7 U54, gB and U90 were amplified from the blood- and
hair-follicle-derived DNA of patient 1 and his mother using external pairs of primers. DNA from Sup.H7 cells was used as a positive
control. GAPDH and 5S were amplified to check the DNA quality in all the samples. (b) Chromosomal integration of HHV-7 in the
peripheral blood cells of patient 1 was tested by FISH analysis. IL2-stimulated PBMCs from patient 1 were used for metaphase-spread
preparation and were co-stained with a Cy5-labelled HHV-7 probe (red) together with a FITC-labelled telomeric PNA probe (green).
DNA was stained with DAPI (blue). Chromosomal integration sites of HHV-7 are indicated with arrows at 60 magnification. Magnified
images of chromosomes carrying integrated HHV-7 are highlighted in the insets. Images from two independent experiments are
shown. (c) Chromosomal integration of HHV-7 in the peripheral blood cells of the mother of patient 1 was tested by FISH analysis as
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DISCUSSION
The presence of similar telomeric repeat sequences at the
genomic ends of both HHV-6 and HHV-7 suggests the pos-
sibility of telomeric integration and germline inheritance of
all the three betaherpesviruses. However, there is no docu-
mented evidence for chromosomal integration of HHV-7.
Moreover, it is believed that HHV-7 is not transmitted ver-
tically via germline integration, as is the case with iciHHV-
6A and -6B, as no congenital HHV-7 was detected in a large
study based on 2129 cord-blood samples [24]. Given the
fact that there have been occasional reports of
cases with very high levels of HHV-7, the possibility of
germ-line transmitted HHV-7 should be explored. With an
aim to compare the amplification efficiency of various
primer pairs designed against different HHV-7 ORFs, we
designed a real-time PCR-based quantitative assay with
a LOD of up to 10 genome equivalents of HHV-7 genome
with more than 99% efficiency within a complex mixture of
human genomic DNA. These primer pairs were further vali-
dated in newly developed Sup.H7 cells carrying latent and
chromosomally integrated HHV-7 infection. During further
experimental validation of the primer pairs, we faced an
unprecedented situation, in which three of the primer pairs
(U4, gB and U54) were unable to amplify viral genome in
human-patient-derived genomic DNA containing HHV-7.
In one of the cases (patient 1), we used external primer pairs
and were able to amplify low levels of HHV-7. After
sequence analysis of these amplimers, we could not detect
any alterations within the genomic regions that could pre-
vent primer binding. The low levels of viral DNA amplified
by U4, gB and U54 primers (Fig. 3a) could originate from
superinfected viral DNA, preventing any conclusion
being made regarding the origin of the viral DNA. However,
our study strongly suggests that primer design can play a
crucial role in HHV-7 detection. Primers designed against
U90 were highly efficient in cell-culture-derived materials as
well as human biological samples, whereas primers against
U4, gB and U54 were not efficient against viral DNA
derived from in vivo patient materials.
G-rich DNA within eukaryotic genomes can form highly
stable G-quadruplex tetrad structures, which are known to
inhibit sequence-specific amplification of DNA [23, 25].
Bioinformatic sequence analysis using QGRS Mapper [26]
predicted the possible formation of G-quadruplex structures
within the reverse primer binding regions of one of the
primer pairs (gB). This might explain the complex nature of
the sequences within this region that could prevent reverse
primer binding in human clinical samples. However, we did
not detect a stable genomic structure within the U4 and
U54 region that could also prevent primer binding.
Moreover, it is difficult to understand the sequence com-
plexity of the same viral DNA under natural infection con-
ditions and in vitro cell culture that decides DNA synthesis
capability. Our results clearly show that primers designed
and validated with cell culture infected virus may not work
with equal efficiency in clinical materials. Extreme caution
should be taken while designing primers for PCR-based epi-
demiological studies and primers should be extensively vali-
dated using positive clinical materials.
We analysed the possibility of chromosomal integration of
HHV-7 in various cell types including cells from HHV-7
positive patients and found evidence for chromosomal inte-
gration of HHV-7 into host cell telomeres suggesting HHV-
7 to be the third roseolovirus known to integrate into
human telomeric repeat sequences. We identified two clini-
cal cases carrying latent HHV-7 in hair follicles. However,
we detected 1 genome equivalent of HHV-7 in the blood of
one of the cases (patient 2) and ~2.6 viral genome equiva-
lents in the hair follicle of his mother, suggesting a possible
case of inheritance of chromosomally integrated latent
HHV-7. However, we could not find similar copies of latent
viral genome in the blood of patient 1 and his mother. We
could only detect 0.01 genome equivalents of viral DNA per
cell by qPCR and integrated viral DNA in a few blood cells
by FISH. This might suggest the highly unstable nature of
integrated viral DNA in fast-replicating cells. However,
HHV-7 shares CD4+ T-cell specificity [27] with varicella
zoster virus [28], suggesting the possibility of similar infec-
tion properties to varicella zoster virus, which accumulates
in the skin at the base of hair follicles [29, 30] after initial
replication. Thus, endothelial cells at the base of hair fol-
licles could provide a unique niche for the virus to achieve
latency.
Here, we report the generation of a latent HHV-7 cell line
(Sup.H7) carrying ~1 genome equivalent of HHV-7 per cell
that could be reactivated using chemical stimuli like trichos-
tatin A and hydrocortisone. Our study provides the first-
ever molecular evidence, to our knowledge, for possible
chromosomal integration of HHV-7, and demonstrates acti-
vation of latent chromosomally integrated HHV-7 under
the influence of chemical stimuli. HHV-7 has been associ-
ated with seizures and encephalitis, and reactivates rarely in
transplant patients’ skin diseases. New insight into HHV-7
latency and its activation should encourage researchers to
expand investigations into the possible role of the virus in
human disorders.
METHODS
All the methods were carried out in accordance with
approved guidelines.
above. (d) Chromosomal integration of HHV-7 in the peripheral blood cells of patient 2 was tested by FISH analysis as above.
(e) The PCR efficiency of the four sets of primers was tested in Sup.H7 cells and compared to that of nested PCR using blood-derived
DNA from patient 2. Amplimers from external primer pairs are marked by black arrowheads and those from nested PCR with internal
primer pairs are marked by red arrowheads.
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Cell lines and HHV-7 infection
Sup.H7 and SupT1 cells were grown in RPMI 1640 media
containing 5–10% FBS at 37

C and 5% CO2. Productive
infection of SupT1 cells with HHV-7(JI) has been described
elsewhere [31].
Generation of Sup.H7 cells
The Sup.H7 cell line was generated by co-cultivating unin-
fected SupT1 cells [31] with HHV-7(RK)-infected cells at a
ratio of 9 : 1 and then culturing the cells for 2–3 months
until the cells lost all signs (ballooning, refractile cytopathic
effect, no expression of late viral proteins) of active viral
infection but still contained a mean of >1 virus genome per
cell. The presence of HHV-7 genomes in the Sup.H7 cells
was confirmed by fluorescence in situ hybridization. Viral
latency in these cells was confirmed by analysing viral copy
number in the absence of a detectable amount of late viral
mRNAs or viral glycoproteins.
Preparation of plasmids and standard curve
analysis
To generate known numbers of copies of viral genome for
standard curve analysis, HHV-7 genomic regions were
amplified and purified PCR products were cloned into
TOPO pCR 2.1 vector (Life Technologies). Cloned DNA
vectors were used to transform Escherichia coli DH5a and
propagated to isolate ample amount of vectors for qPCR
analysis. Cloned ORFs were verified by DNA sequencing.
Standard curve analysis for human PI15 ORF has been
described before [18].
Primers and probes
A cocktail mixture of five different purified PCR products
amplified from different genomic regions of HHV-7(JI) was
used as a FISH probe. The sequences of oligomers used to
amplify probe sequences by PCR are provided in Table S1.
After purification, the amplimers were labelled with the Cy5
fluorophore using a nick translation kit (PromoFluor-640
nick translation labelling kit; PromoKine) and then purified
before use. FITC-labelled C-rich telomere probe (PN-
TC011-005) was purchased from Eurogentech.
Chlamydia trachomatis infection
Sup.H7 cells were infected with C. trachomatis strain LGV-L2
434/Bu at an m.o.i. of 1–5 as described previously [16, 18].
DNA extraction
Genomic DNA from the peripheral blood of patient 1 and
patient 2 and cultured cells was extracted using a QIAamp
DNA mini kit (Qiagen) following the manufacturer’s proto-
col. DNA extraction from hair follicles was carried out using
QuickExtract DNA extraction solution (Epicentre) and
Extracta DNA Prep PCR – tissue (Quanta Biosciences).
qPCR
qPCR was carried out and is explained here following the
published MIQE guidelines [32]. PerfeCTa qPCR SuperMix
(Quanta Biosciences) was used for qPCR. Amplifications
were done on a StepOnePlus real-time PCR platform
(Applied Biosciences) using the manufacturer‘s protocol
and SYBR Green chemistry. Amplification data were ana-
lysed using StepOne software v2.1. A total of 100–150 ng
cellular DNA was used for every reaction. Total DNA iso-
lated from SupT1 cells carrying active HHV-7(JI) infection
and Sup.H7 cells carrying latent HHV-7 genome were used
as positive controls in every reaction. Amplification of cellu-
lar gene PI15 was used for normalization and calculation of
the number of cell copies in every reaction.
Nested PCR
For nested PCR, the first PCR amplification was carried out
only for 25 cycles. The PCR product obtained was diluted
100 times and was used for nested PCR for another 25
cycles. All the semi-quantitative PCRs were carried out
using the following temperature profile: initial denaturation
at 98

C for 2min; 25 cycles of denaturation at 95

C for
30 s, primer binding at 60

C for 30 s and primer extension
at 72





Cells were washed in PBS and fixed with 4% paraformalde-
hyde for 30min at room temperature. After washing, cells
were permeabilized using 0.2% Triton X-100 in PBS for
15min and blocked with 10% FCS in PBS for 1 h at room
temperature. Cells were incubated for 1 h with the primary
antibody in blocking buffer (2% FCS in PBS), washed three
times in PBS and stained with the corresponding secondary
antibody. DAPI was used for staining cell nuclei. After
washing three times with PBS, samples were mounted onto
slides using Mowiol (Carl Roth). Samples were analysed
with a Leica DMR epifluorescence microscope. HHV-7 U27
and KR4 antibodies were obtained from the HHV-6 Foun-
dation, USA.
RNA extraction and semi-quantitative reverse-
transcription PCR (RT-PCR)
RNA extraction, cDNA synthesis and subsequent semi-
quantitative RT-PCR were performed as previously
described [33].
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